First Long Island Investors’s AstraZeneca AZN Stock Holding History

First Long Island Investors’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$364K	Hold	1,920	–	–	0.03%	59
2026 Q1	$379K	Sell	1,920 -1	-0.1%	-$193	0.03%	54
2025 Q4	$353K	Hold	1,921	–	–	0.03%	58
2025 Q3	$295K	Hold	1,921	–	–	0.02%	57
2025 Q2	$268K	Hold	1,921	–	–	0.02%	57
2025 Q1	$282K	Hold	1,921	–	–	0.02%	60
2024 Q4	$252K	Hold	1,921	–	–	0.02%	63
2024 Q3	$299K	Hold	1,921	–	–	0.02%	62
2024 Q2	$300K	Buy	+1,921	New	+$289K	0.03%	58

Other funds holding AZN

Evelyn Partners London $46.9B AUM

Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

First Long Island Investors's AZN Position: Q2 2026 in Review

First Long Island Investors held its AstraZeneca (AZN) position steady in Q2 2026 at 1,920 shares worth $364K. The position accounts for 0.03% of the portfolio, ranked #59.

First Long Island Investors first reported a position in AZN in Q2 2024 and has held it in 9 quarters since. The position peaked at $379K in Q1 2026. 1,507 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

First Long Island Investors held 1,920 shares of AstraZeneca worth $364K as of Q2 2026.
First Long Island Investors left its AstraZeneca share count unchanged in Q2 2026.
AstraZeneca made up 0.03% of First Long Island Investors's portfolio in Q2 2026, its #59 holding.
First Long Island Investors first reported a position in AstraZeneca in Q2 2024 and has held it in 9 quarters since.
First Long Island Investors's AstraZeneca position peaked at $379K in Q1 2026.
1,507 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on First Long Island Investors's 13F filing for Q2 2026, filed 13 Aug 2026.